*Bencharif K et al. (2010) Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes. Lipids in Health and Disease 9:75*Mastricci AL et al. (2011) Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks? Fetal Diagn Ther. 30(1):53-59* Boeva OI et al. (2014) ANALYSIS OF INDICATORS OF LIPID METABOLIS IN CALCINATING DISEASES OF THE AORTAL VALVE. Basic research. 7(1):21-25* Elena S et al. (2014) Gene polymorphism of lipid metabolism markers in calcific aortic valve disease.DOI - http://dx.doi.org/10.14300/mnnc.2014.09053. ISSN - 2073-8137*Sharma S et al. (2014) Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers. Sci Rep. 4:7140. doi: 10.1038/srep07140*Shcheglova EV et al. (2014) Gene ploymorphism of lipid metabolism markers in calcific aortic valve disease.Medical News of the North Caucasus. ISSN-2073-8137* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113* Shcheglova EV et al. (2017) Genotypes and serum levels of apolipoprotein E and paraoxonase 1 in calcific aortic valve stenosis. Russian Cardiology Journal No. 10 (150):107-112* Nowak JK et al. (2019) Cystic fibrosis dyslipidaemia: A cross-sectional study. J Cyst Fibros. 18(4):566-571